Click here to view online. Add this email to your safelist.
Advancing early diagnosis and monitoring for respiratory diseases
14 February 2024
In partnership with ArtiQ, we are exploring the potential of AI to enable at-home spirometry testing to support faster, more patient centric clinical trials and potentially to improve disease diagnosis and monitoring.
|
|||||
|
|||||
|
For more information please visit astrazeneca.com. If you would like to unsubscribe please click here. |
